Deep Currents Investment Group LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $46 Million distributed in 321 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Western Digital Corp with a value of $10.6M, Jd.Com, Inc. with a value of $5.44M, Biomarin Pharmaceutical Inc with a value of $5.04M, Maxeon Solar Technologies, Ltd. with a value of $2.24M, and Champion X Corp with a value of $2M.
Examining the 13F form we can see an decrease of $15.1M in the current position value, from $61.1M to 46M .
Deep Currents Investment Group LLC is based out at New York, NY
Below you can find more details about Deep Currents Investment Group LLC portfolio as well as his latest detailed transactions.
Portfolio value
$46 Million
$20 Million
$9.52 Million
$5.5 Million
$3.2 Million
$2.55 Million
$2.16 Million
$1.84 Million
$658,000
$603,000
Stock Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q3 2024
Added 28.57%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 25.0%
-
$0
0.0% of portfolio
-
Q3 2024
Added 29.46%
-
$0
0.0% of portfolio
-
Q2 2024
Added 25.32%
-
$0
0.0% of portfolio
-
Q3 2024
Added 10.69%
-
$0
0.0% of portfolio
-
Q2 2024
Added 9.12%
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 20.0%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 27.27%
-
$0
0.0% of portfolio
-
Q3 2024
Added 19.51%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 8.85%
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 49.25%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 50.26%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 10.05%
-
$0
0.0% of portfolio
-
Q3 2024
Added 111.23%
-
$0
0.0% of portfolio
-
Q3 2024
Added 128.66%
-
$0
0.0% of portfolio
-
Q2 2023
Reduced 14.63%
-
$0
0.0% of portfolio
-
Q3 2024
Added 4.57%
Solaredge Technologies Inc
-
$0
0.0% of portfolio
-
Q3 2024
Added 136.94%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 6.51%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 7.08%
-
$0
0.0% of portfolio
-
Q1 2024
Added 9.52%
-
$0
0.0% of portfolio
-
Q4 2022
Reduced 7.03%
-
$0
0.0% of portfolio
-
Q3 2024
Added 18.85%
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 4.48%
-
$0
0.0% of portfolio
-
Q2 2024
Added 33.41%
-
$0
0.0% of portfolio
-
Q3 2024
Added 44.2%
-
$0
0.0% of portfolio
-
Q3 2024
Added 44.35%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 26.49%
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q1 2024
Added 27.77%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 38.65%
-
$0
0.0% of portfolio
-
Q4 2023
Added 43.46%
-
$0
0.0% of portfolio
-
Q3 2024
Added 25.96%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 461.48%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q1 2024
Added 31.15%
-
$0
0.0% of portfolio
-
Q1 2024
Added 11.92%
-
$0
0.0% of portfolio
-
Q3 2024
Added 53.57%
-
$0
0.0% of portfolio
-
Q3 2024
New
Apellis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2024
Added 46.46%
-
$0
0.0% of portfolio
-
Q4 2023
Added 22.25%
